DXP Enterprises Authorizes $150 Million Stock Repurchase Program
1 report, 1 independent
Updated Wed 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The board of directors of DXP Enterprises, Inc. authorized a new stock repurchase program on October 28, 2026. This plan allows the company to acquire up to $150.0 million or 1.0 million shares of common stock over the next 24 months. The previous stock repurchase program concluded in August 2026.
From thewhig.com
Why it matters
The authorization of a new stock repurchase program may affect the company's capital structure and market valuation. The plan allows management to acquire shares at prevailing market prices through open market or privately negotiated transactions.
From thewhig.com
Who's involved
- board of directorsAuthorized the new stock repurchase program for DXP Enterprises, Inc.
Keep exploring
The entities involved
-
board of directors
group of people who jointly supervise the activities of an organization
Related events
- Aclarion's board of directors authorized a stock repurchase program on August 6, 2026.
- A company listed on Nasdaq approved a share repurchase program.
- The board of directors of a company increased its share repurchase authorization on September 10, 2026.
- The board of directors authorized a $3 billion share repurchase program on October 22, 2026.
- Nektar Therapeutics' board granted stock options to new employees on October 23, 2026.